Skip to content

Prophylactic Radiofrequency Left Atrial Posterior Wall Isolation to Prevent Atrial Fibrillation After Cardiac Surgery

Prophylactic Radiofrequency Left Atrial Posterior Wall Isolation (box Lesion Ablation) to Prevent Atrial Fibrillation After Cardiac Surgery (PROBOX): a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06823778
Acronym
PROBOX
Enrollment
216
Registered
2025-02-12
Start date
2025-02-17
Completion date
2027-09-30
Last updated
2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Atrial Fibrillation

Keywords

Postoperative Atrial Fibrillation, Radiofrequency Ablation, Box Lesion Ablation, Prophylactic Ablation

Brief summary

The goal of this clinical trial is to learn if an epicardial radiofrequency left atrial posterior wall isolation (box lesion ablation) prevents atrial fibrillation after cardiac surgery. The main question it aims to answer is: \- Does box lesion ablation lower the number of patients experiencing de-novo atrial fibrillation requiring any treatment after cardiac surgery? Researchers will compare box lesion ablation to no ablation to see if ablation prevents postoperative atrial fibrillation. Participants will undergo ablation or no ablation at the time of other cardiac surgery. Data will be collected while in hospital. Additional information will be collected on 30th day after surgery by telephone call or during a visit.

Detailed description

Postoperative atrial fibrillation (POAF) is a common complication after heart surgery that occurs in 10-60% of patients. It can cause hypotension, tachycardia, stroke, systemic embolism, or heart failure, and is associated with increased mortality rates, prolonged hospital stays and increased costs. Several studies have investigated the use of radiofrequency ablation (the standard of surgical care for atrial fibrillation during concomitant cardiac surgery when the diagnosis is known preoperatively) to prevent POAF. However, these studies were limited mainly to pulmonary vein isolation and had methodological limitations such as small sample sizes, inclusion/exclusion criteria, and randomization procedures, and have not translated into clinical practice changes. The current study aims to investigate the use of radiofrequency left atrial posterior wall isolation, also known as box lesion ablation, as a more effective treatment compared to pulmonary vein isolation, in a properly designed randomized controlled trial.

Interventions

DEVICERadiofrequency ablation

In this group of patients, epicardial radiofrequency left atrial posterior wall isolation will be performed with AtriCure Isolator Synergy OLL2 bipolar radiofrequency clamp without opening the left atrium.

Sponsors

Vasily I. Kaleda
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Intervention model description

A Prospective Parallel-Arm Single-Blind Randomized Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients undergoing cardiac surgery by a single surgeon (V.K.) * Informed consent

Exclusion criteria

* History of atrial fibrillation/flutter * Minimally invasive approach * Off-pump surgery * Emergent/salvage surgery * Severe pericardial adhesions

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Atrial FibrillationWithin 30-day of surgery or until discharge, whichever came last, assessed up to 6 months after surgeryIncidence of clinically significant (requiring any type of intervention) postoperative atrial fibrillation

Secondary

MeasureTime frameDescription
Postoperative MortalityWithin 30-day of surgery or until discharge, whichever came last, assessed up to 6 months after surgeryAll deaths occurring during the hospitalization in which the operation was performed, even if after 30 days; and all deaths occurring after discharge from the hospital, but before the end of the 30th postoperative day.
Postoperative StrokeWithin 30-day of surgery or until discharge, whichever came last, assessed up to 6 months after surgeryNumber of patients who have a postoperative stroke (i.e., any confirmed neurological deficit of abrupt onset caused by a disturbance in blood supply to the brain) that did not resolve within 24 hours
Length of StayUp to 6 months after surgeryPostoperative length of in-hospital stay
Unplanned ReadmissionWithin 30 days after surgeryUnplanned 30-day any cause readmission rate

Other

MeasureTime frameDescription
Cardiopulmonary bypass timeUp to 24 hours after the start of the operationTotal cardiopulmonary bypass time (min)
Cross-clamp timeUp to 24 hours after the start of the operationTotal cross-clamp time (min)
Other arrhythmias rateWithin 30-day of surgery or until discharge, whichever came last, assessed up to 6 months after surgeryAny arrhytmias other than POAF rate
Operative timeUp to 24 hours after the start of the operationTotal operative time (min)

Countries

Russia

Contacts

Primary ContactVasily I. Kaleda, M.D., Ph.D.
vasily.kaleda@gmail.com7 (985) 641 1769

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026